ArticleMedicine2020

Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus.

Eun-Hee Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.